Gastroschisis: Clinical Trials

3 trials for Gastroschisis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Completed 1
Phase 11Terminated 1
Phase 31Completed 1

Follow Gastroschisis: new trials by email Literature Review of Gastroschisis trials Research Report on Gastroschisis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Compassionate Use of Omegaven in Children
Omegaven - Total Parenteral Nutrition-induced Cholestasis, Cholestasis
Phase 2 / Phase 3CompletedUniversity of Oklahoma632015-06-012019-11-25
Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome
Phase 1 / Phase 2TerminatedAlberta Children's Hospital132012-01-012014-12-23
Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis
Primary placement of a spring-loaded silo, Primary Closure - Gastroschisis
Phase 2TerminatedThe Hospital for Sick Children882001-06-012024-06-24

Narrower conditions

Intestinal Atresia (2)  ·  Short Bowel Syndrome (2)  ·  Cholestasis (1)  ·  Enterocolitis, Necrotizing (1)  ·  Infant Nutrition Disorders (1)  ·  Infant, Premature, Diseases (1)  ·  Intestinal Failure (1)  ·  Malnutrition (1)

Broader conditions

Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Hernia (3)  ·  Hernia, Abdominal (3)  ·  Musculoskeletal Abnormalities (3)  ·  Musculoskeletal Diseases (3)  ·  Pathological Conditions, Anatomical (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Digestive System Abnormalities (2)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Malabsorption Syndromes (2)  ·  Pathologic Processes (2)  ·  Postoperative Complications (2)

Interventions

Glucagon-Like Peptide 2 (1)  ·  fish oil triglycerides (1)

Sponsors

Alberta Children's Hospital (1)  ·  The Hospital for Sick Children (1)  ·  University of Oklahoma (1)

Countries

Canada (2)  ·  United States (1)

Top investigators

David Sigalet, MD PhD (1)  ·  Jacob Langer, MD (1)  ·  Kimberly D Ernst, MD, MSMI (1)

Results publications

PMID 18926212